Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures
- 23 April 2024
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 408, 132091
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Artificial intelligence-augmented analysis of contemporary procedural, mortality, and cost trends in carcinoid heart disease in a large national cohort with a focus on the “forgotten pulmonic valve”Frontiers in Cardiovascular Medicine, 2023
- Outcomes of Patients With Cancer Who Underwent Transcatheter Mitral Valve Repair With MitraClipThe American Journal of Cardiology, 2022
- 2021 ESC/EACTS Guidelines for the management of valvular heart diseaseEuroIntervention, 2022
- Transcatheter Mitral Valve Therapy in the United StatesJACC, 2021
- Transcatheter Mitral Valve Implantation: Current Status and Future PerspectivesCirculation: Cardiovascular Interventions, 2021
- Machine Learning-Augmented Propensity Score Analysis of Percutaneous Coronary Intervention in Over 30 Million Cancer and Non-cancer PatientsFrontiers in Cardiovascular Medicine, 2021
- Impact of cancer history on clinical outcome in patients undergoing transcatheter edge-to-edge mitral repairClinical Research in Cardiology, 2020
- Contemporary Trends and Outcomes of Percutaneous and Surgical Mitral Valve Replacement or Repair in Patients With CancerThe American Journal of Cardiology, 2020
- Previous malignancy is an independent predictor of follow‐up mortality after percutaneous treatment of mitral valve regurgitation by means of MitraClipCardiovascular Therapeutics, 2017